Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease.
about
Fibrinogen-induced endothelin-1 production from endothelial cellsHemostatic factors and risk of coronary heart disease in general populations: new prospective study and updated meta-analysesThe association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4,610 cases amongst 18,637 participantsAre markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?High-Sensitive C-Reactive Protein Levels in a Group of Syrian University Male Students and Its Associations with Smoking, Physical Activity, Anthropometric Measurements, and Some Hematologic Inflammation Biomarkers.Socioeconomic inequalities in coronary heart disease risk in older age: contribution of established and novel coronary risk factors.Total hip and knee replacement surgery results in changes in leukocyte and endothelial markersAndrogen activity and markers of inflammation among men in NHANES IIINovel cardiovascular risk markers in women with ischaemic heart disease.Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.A quantitative trait locus on chromosome 5p influences d-dimer levels in the san antonio family heart study.Effects of Endurance Training on the Serum Levels of Tumour Necrosis Factor-α and Interferon-γ in Sedentary Men.Association of soluble endothelial protein C receptor plasma levels and PROCR rs867186 with cardiovascular risk factors and cardiovascular events in coronary artery disease patients: the Athero Gene study.Depression is the strongest predictor of long-term outcome in patients with chronic nonischemic heart failureCirculating endothelial cells in patients with venous thromboembolism and myeloproliferative neoplasms.C-reactive protein and lipid parameters in older persons aged 80 years and older.Mild episodes of tourniquet-induced forearm ischaemia-reperfusion injury results in leukocyte activation and changes in inflammatory and coagulation markers.Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features.Plasma levels of complement proteins from the alternative pathway in patients with age-related macular degeneration are independent of Complement Factor H Tyr⁴⁰²His polymorphism.Study on Subclinical Hypothyroidism and its Association with Various Inflammatory Markers.Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy.Cardiovascular health and the menopause: the gynecologist as the patients' interface.Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism.Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration.Vitamin C in disease prevention and cure: an overviewAssociations between urinary soy isoflavonoids and two inflammatory markers in adults in the United States in 2005-2008.Lower limb orthopaedic surgery results in changes to coagulation and non-specific inflammatory biomarkers, including selective clinical outcome measures.A Relationship between the Obstructive Sleep Apnea Syndrome and the Erythrocyte Sedimentation RateLong-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease.Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels.Stroke and Death Prediction with the Impact of Vascular Disease in Patients with Atrial Fibrillation.Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans.From circulating biomarkers to genomics and imaging in the prediction of cardiovascular events in the general population.Fibrinogen as a key regulator of inflammation in disease.Hyperfibrinogenemia in appendicitis: a new predictor of perforation in children.Personalized protein corona on nanoparticles and its clinical implications.Thrombin generation in patients with a first acute myocardial infarction.Immune alterations in acute bipolar depression.Docking study of novel antihyperlipidemic thieno[2,3-d]pyrimidine; LM-1554, with some molecular targets related to hyperlipidemia - an investigation into its mechanism of action.The association between elevated levels of inflammation biomarkers and coronary artery disease and death.
P2860
Q24336335-02D92D5B-8751-4130-A3ED-2FD46EB5D613Q26993237-E4F8E0C9-CF9B-4F28-9272-342B19C31EC2Q33361657-71EF633D-6A24-424C-9CD5-096AB0A6A53BQ33474334-7A7AE74C-E45F-453F-A787-E0615B00F72BQ33594123-7F0BCBCD-6124-4B36-84F5-C930F8829516Q33606543-C9018716-33E0-431D-A9FD-15B4EAC98F98Q33645174-3986E434-6048-4FCB-A321-E3B056643020Q33647847-F2804B27-35F0-4434-B712-98095DE42865Q33995037-9726D867-FEAA-4189-8004-C74880DAA86FQ34204026-464055B6-F03E-451B-BEAB-06A507FF2D50Q34340312-0E5F3A3E-F5DA-4CF3-9412-5B6CA7447A7CQ34416652-C8C020A8-A7EE-4111-870C-E4B8F2A14B3DQ34471057-DD15E60A-4FC9-4AC7-8DCF-AABFC52E880DQ34821932-23FD90AE-F803-4202-8978-3A9A4DA5D4C5Q35067553-A3964AC8-9019-48FA-87A6-5AD4261B2059Q35282669-B90DC4B9-1F9F-47AF-AF05-891142403A96Q35839224-AAE45604-CE81-4CAE-82C4-2F5CC9C04711Q36031032-69294129-11B2-4FBC-AEC1-283F451F3C6EQ36218190-EF565127-DAA9-497C-B678-97EE85C2BEA8Q36343406-E4A0D28A-E222-4206-B9B1-E623B019E8D6Q36561084-DCA92B0A-2CDE-417C-9374-5BE30A4B1C45Q36561352-874375BA-2E7F-4591-BC98-909C462FCBE3Q36642140-B6C8E026-EB53-40C8-B61F-25167C71D405Q36836558-56ABC446-B2D7-4410-8571-1CABCC6A35D5Q37199413-7296F2AE-0E85-4AD7-A011-F6AEBB434439Q37233040-66211C29-0F76-4848-BCF3-AC345A4F5CC6Q37320412-41EE870D-6A1D-48F8-9F26-CF9699AF1C15Q37362661-2C635474-36CA-4F95-BD98-0B6C5B06D7B0Q37376934-C53E2EF0-7162-4D53-8200-3BFAB0D619F2Q37385098-40E26934-CE98-4E77-BC2E-2EBA756BF60EQ37495877-C76C6FE9-3E22-429E-9BE7-E4C457F0889EQ37545061-2997B8CC-98A8-4365-AB2B-36199E9082F3Q37881966-CE062166-7645-482C-84C6-F214A996ABC4Q37950860-BB31D06A-8B6D-438B-9124-AC37D33FBC7CQ38239421-3A88225A-3B16-40AA-BC29-57D2B5D3B51FQ39108612-A3B29848-7398-4346-99F6-F25416C795E6Q39807597-33D095A7-1BAE-427B-8279-04B25C5F8EBFQ41681841-ED63F5A1-1B46-4CEF-839C-D678FD22D11EQ42976849-4FF7E3E1-D1D7-415E-AFC7-A2A406E81476Q43212282-B8989845-5232-4348-9A18-DDC667FCBA2B
P2860
Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Circulating inflammatory marke ...... nd non-cardiovascular disease.
@ast
Circulating inflammatory marke ...... nd non-cardiovascular disease.
@en
type
label
Circulating inflammatory marke ...... nd non-cardiovascular disease.
@ast
Circulating inflammatory marke ...... nd non-cardiovascular disease.
@en
prefLabel
Circulating inflammatory marke ...... nd non-cardiovascular disease.
@ast
Circulating inflammatory marke ...... nd non-cardiovascular disease.
@en
P2860
P1476
Circulating inflammatory marke ...... nd non-cardiovascular disease.
@en
P2093
P2860
P304
P356
10.1111/J.1538-7836.2005.01416.X
P577
2005-08-01T00:00:00Z